Company research
Baird Medical Investment Holdings Ltd
CIK 1982444Updated Sep 24, 2026
BDMD price & chart
Loading TradingView…
NASDAQ:BDMD on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 69,701,015Source | 77,962,870Source | 56,708,389Source |
| Property, Plant and Equipment, NetUSD | 6,370,900Source | 7,141,064Source | 6,138,694Source |
| GoodwillUSD | 60,303Source | 57,772Source | 59,375Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 8,626Source | 16,528Source | 25,479Source |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 178,321Source | — | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 42,528,919Source | 46,575,776Source | 31,099,891Source |
| Inventory, NetUSD | 1,085,783Source | 1,296,577Source | 1,142,569Source |
| Assets, CurrentUSD | 54,969,518Source | 61,415,375Source | 40,082,702Source |
| Operating Lease, Right-of-Use AssetUSD | 175,160Source | 475,119Source | 861,331Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 38,477,473Source | 38,202,392Source | 21,001,134Source |
| Stockholders’ equity: | |||
| Preferred Stock, Value, IssuedUSD | 29Source | 29Source | — |
| Common Stock, Value, IssuedUSD | 3,075Source | 2,556Source | 2,556Source |
| Additional Paid in CapitalUSD | 28,658,524Source | 11,441,712Source | 18,850,677Source |
| Retained Earnings (Accumulated Deficit)USD | -515,415Source | 26,764,751Source | 14,394,167Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,371,894Source | -3,141,061Source | -2,005,122Source |
| Stockholders' Equity Attributable to ParentUSD | 31,367,631Source | 39,659,138Source | 35,750,644Source |
| Liabilities and EquityUSD | 69,701,015Source | 77,962,870Source | 56,708,389Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 32,363,582Source | 34,623,183Source | 18,975,434Source |
| Operating Lease, Liability, CurrentUSD | 115,031Source | 264,316Source | 503,891Source |
| Accounts Payable, CurrentUSD | 1,805,042Source | 1,252,667Source | 550,188Source |
| Operating Lease, Liability, NoncurrentUSD | 27,637Source | 136,683Source | 412,121Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -144,089Source | 101,340Source | -43,389Source |
| Additional Financial Items | |||
| Long-term Debt, Current MaturitiesUSD | 2,637,036Source | 867,772Source | 817,485Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 6,086,254Source | 3,442,526Source | 1,613,579Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -27,541,124Source | 12,598,098Source | 10,658,183Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 17,471,081Source | — | — |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts ReceivableUSD | -5,348,047Source | 17,799,751Source | 9,674,507Source |
| Increase (Decrease) in InventoriesUSD | -260,281Source | 187,543Source | -113,661Source |
| Increase (Decrease) in Accounts PayableUSD | 483,945Source | 727,800Source | 341,525Source |
| Deferred Income Tax Expense (Benefit)USD | -53,499Source | 32,774Source | -541,987Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -1,344,032Source | -6,313,115Source | -1,019,964Source |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -42,315Source | -2,853,678Source | -2,638,488Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 42,315Source | 2,853,678Source | 2,638,488Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -1,393,823Source | 10,720,781Source | 3,461,118Source |
| Repayments of Long-term DebtUSD | 2,282,213Source | 806,764Source | 194,041Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -2,404,382Source | 1,459,715Source | -200,442Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 565,817Source | 2,970,199Source | 1,510,484Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 737,671Source | 497,247Source | 261,323Source |
| Income Taxes Paid, NetUSD | 836,584Source | 1,837,708Source | 2,644,786Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 375,788Source | -94,273Source | -3,108Source |
| Additional Financial Items | |||
| Share-based Payment Arrangement, ExpenseUSD | 17,500,000Source | — | — |
| Amortization of Intangible AssetsUSD | 8,391Source | 8,384Source | 22,637Source |
| DepreciationUSD | 1,095,693Source | 1,130,747Source | 991,750Source |
| General and Administrative ExpenseUSD | 14,119,024Source | 7,103,226Source | 8,546,880Source |
| GoodwillUSD | 60,303Source | 57,772Source | 59,375Source |
| Goodwill, Impairment LossUSD | 0Source | — | — |
| Impairment of Intangible Assets, Finite-livedUSD | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | 1,166,148Source | 1,489,190Source | 1,701,019Source |
| InterestExpenseNonoperatingUSD | 737,370Source | 576,752Source | 285,833Source |
| Investment Income, InterestUSD | — | 393Source | 1,562Source |
| Net Income (Loss) Attributable to ParentUSD | -27,278,005Source | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -263,119Source | 144,729Source | 112,205Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -27,278,005Source | 12,453,369Source | 10,545,978Source |
| Operating ExpensesUSD | 44,514,543Source | 17,338,707Source | 15,368,774Source |
| Operating Lease, ExpenseUSD | — | 400,000Source | 400,000Source |
| Other Nonoperating Income (Expense)USD | -100,195Source | -651,657Source | -10,211Source |
| Proceeds from Issuance of Long-term DebtUSD | 6,391,228Source | 2,780,000Source | 2,548,794Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Total RevenueUSD | 22,537,016Source | 37,037,108Source | 31,457,908Source |
| Cost of Goods and Services Sold | — | — | — |
| Operating Income (Loss)USD | -25,630,805Source | 15,315,038Source | 11,861,725Source |
| Other Nonoperating Income (Expense)USD | -100,195Source | -651,657Source | -10,211Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -26,374,976Source | 14,087,288Source | 12,359,202Source |
| Income Tax Expense (Benefit)USD | 1,166,148Source | 1,489,190Source | 1,701,019Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -263,119Source | 144,729Source | 112,205Source |
| Net Income (Loss) Attributable to ParentUSD | -27,278,005Source | — | — |
| Earnings Per Share, BasicUSD per share | -0.98Source | 0.49Source | 0.41Source |
| Earnings Per Share, DilutedUSD per share | -0.98Source | 0.49Source | 0.41Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 27,792,704Source | 25,555,096Source | 25,555,096Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 27,792,704Source | 25,627,992Source | 25,555,096Source |
| Interest Expense (non-operating)USD | 737,370Source | 576,752Source | 285,833Source |
| Additional Financial Items | |||
| Amortization of Intangible AssetsUSD | 8,391Source | 8,384Source | 22,637Source |
| Current Income Tax Expense (Benefit)USD | 1,219,647Source | 1,456,416Source | 2,243,006Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 1,104,084Source | 1,139,131Source | 1,014,387Source |
| General and Administrative ExpenseUSD | 14,119,024Source | 7,103,226Source | 8,546,880Source |
| Goodwill, Impairment LossUSD | 0Source | — | — |
| Gross ProfitUSD | 18,883,738Source | 32,653,745Source | 27,230,499Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -26,149,558Source | — | — |
| Interest Expense, DebtUSD | 354,341Source | 497,247Source | 227,923Source |
| Interest Income (Expense), Nonoperating, NetUSD | -737,370Source | — | — |
| Investment Income, InterestUSD | — | 393Source | 1,562Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -27,278,005Source | 12,453,369Source | 10,545,978Source |
| Operating ExpensesUSD | 44,514,543Source | 17,338,707Source | 15,368,774Source |
| Operating Lease, ExpenseUSD | — | 400,000Source | 400,000Source |
| Research and Development ExpenseUSD | 20,131,012Source | 6,174,365Source | 4,274,894Source |
| Selling and Marketing ExpenseUSD | 10,264,507Source | 4,061,116Source | 2,547,000Source |